Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Miacalcic (calcitonin) Important Safety Information from Novartis as approved by the Irish Medicines Board

20 August 2012

Important Safety Information communication from Novartis on calcitonin associated with malignancy – withdrawal of Miacalcic 200IU nasal spray, solution from the market.

Important Safety Information - Miacalcic





Date Printed: 19 June 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971